Cargando…
The intestinal microbiota and improving the efficacy of COVID-19 vaccinations
Most COVID-19 cases are mild or asymptomatic and recover well, suggesting that effective immune responses ensue, which successfully eliminate SARS-CoV-2 viruses. However, a small proportion of patients develop severe COVID-19 with pathological immune responses. This indicates that a strong immune sy...
Autores principales: | Chen, Jiezhong, Vitetta, Luis, Henson, Jeremy D., Hall, Sean |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578005/ https://www.ncbi.nlm.nih.gov/pubmed/34777578 http://dx.doi.org/10.1016/j.jff.2021.104850 |
Ejemplares similares
-
Intestinal Dysbiosis, the Tryptophan Pathway and Nonalcoholic Steatohepatitis
por: Chen, Jiezhong, et al.
Publicado: (2022) -
Modulation of Gut Microbiota for the Prevention and Treatment of COVID-19
por: Chen, Jiezhong, et al.
Publicado: (2021) -
Gut Microbiota Metabolites in NAFLD Pathogenesis and Therapeutic Implications
por: Chen, Jiezhong, et al.
Publicado: (2020) -
Gut-brain axis in the neurological comorbidity of COVID-19
por: Chen, Jiezhong, et al.
Publicado: (2021) -
Gut Dysbiosis Could Be a Major Factor for the Effects of Low-Grade Endotoxemia in COVID-19 Comment on: Low-Grade Endotoxemia and Thrombosis in COVID-19
por: Chen, Jiezhong, et al.
Publicado: (2022)